Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:MGR
ASX:MGRREITs

Will Analyst Optimism on Earnings Reversal Change Mirvac Group's (ASX:MGR) Narrative?

In the past three months, Mirvac Group experienced a significant uptick in investor interest despite reporting a low return on equity of 0.8% and a prolonged decline in net income over the past five years. This shift in sentiment is primarily attributed to analyst forecasts predicting a rebound in earnings and a rise in return on equity to 6.1% in the coming years. We’ll explore how analyst optimism for improving profitability may influence Mirvac Group’s broader investment narrative going...
TSX:OLY
TSX:OLYCapital Markets

Can Olympia Financial (TSX:OLY) Monthly Dividends Reveal Insights Into Its Long-Term Strategy?

Olympia Financial Group Inc. recently affirmed a monthly dividend of C$0.60 per share, payable on October 31, 2025, with an ex-date and record date of October 22, 2025. This consistent monthly dividend offering highlights the company's ongoing appeal for investors prioritizing regular income from their equity holdings. We’ll explore how Olympia Financial Group’s ongoing monthly dividend remains a central feature of its investment narrative. Uncover the next big thing with financially sound...
ASX:PCK
ASX:PCKHealthcare Services

Should FDA De Novo Clearance for Adult App Prompt a Rethink by PainChek (ASX:PCK) Investors?

PainChek has received De Novo clearance from the US FDA for its Adult App, authorizing it as the first regulated medical device for pain assessment in individuals who cannot reliably self-report, including those with dementia, thus unlocking access to the US aged care market. The clearance not only enables immediate US commercial rollout but also paves the way for expanded opportunities in international markets that recognize FDA data standards, such as Japan and Germany. We'll now explore...